The Cholangiocarcinoma Foundation Appoints New Executive Director

Discussion Board Forums Announcements The Cholangiocarcinoma Foundation Appoints New Executive Director

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • #81312
    darla
    Spectator

    Welcome Donna and thank you for joining us. Darla

    #81311
    lisacraine
    Spectator

    Welcome Donna,
    This is a wonderful and warm group of people.
    Lisa

    #81310
    lainy
    Spectator

    Welcome Donna to our extraordinary family, this is very exciting and I know you will be kept extremely busy! Kim, thank you for all you have done and wishing you the best of everything!

    #9761
    gavin
    Moderator

    Welcome Donna and thank you!

    The Cholangiocarcinoma Foundation Appoints New Executive Director

    The Cholangiocarcinoma Foundation Begins Transition to New Executive Leadership

    Salt Lake City, Utah – March 17, 2014

    The Cholangiocarcinoma Foundation announced today that Donna Mayer has been appointed Acting Executive Director. Donna has developed and implemented innovative programs and services for non-profit organizations including DIA and the Hepatitis B Foundation. She has a long history serving as an advocate providing support and information to patients and the allied healthcare community worldwide.

    CCF President, Stacie Lindsey, described the appointment as a very significant step for the organization. “Donna has a successful track record of implementing effective global strategies and we are looking forward to her leadership and guidance.” She added “We would like to thank Kim Crittenden for her service to the foundation this year and moving us forward on several important areas. We wish her well in her future endeavors.”

    Donna is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation and a long-time volunteer with the Bucks County and Keystone Crisis Intervention Teams. Her collaborations with other organizations include the Patient Centered Outcomes Research Institute, Clinical Trials Transformation Initiative, National Organization for Rare Disorders, International Association of Patient Organizations, and regulatory agencies such as the Food and Drug Administration and European Medicines Agency.

    “I look forward to building a strong foundation to assure a solid infrastructure and continued growth with an eye on delivering quality programs and services to our constituents worldwide. My goal is to establish strategic partnerships with global stakeholders — particularly among the regulatory, scientific, industry, academic, and patient communities in order to drive transformation and truly meet the mission of The Cholangiocarcinoma Foundation.

    The Cholangiocarcinoma Foundation is a 501(c) (3) non-profit organization. Its vision is to bring about a C.U.R.E. for Cholangiocarcinoma through Collaboration, Understanding, Research, and Education.

Viewing 4 posts - 1 through 4 (of 4 total)
  • The forum ‘Announcements’ is closed to new topics and replies.